Cardiac involvement in systemic sclerosis: differences between clinical subsets and influence on survival

Andreu Fernández-Codina, Carmen Pilar Simeón-Aznar, Iago Pinal-Fernandez, José Rodríguez-Palomares, Maria Nazarena Pizzi, Cristina Eve Hidalgo, Alfredo Guillén Del Castillo, Francisco Javier Prado-Galbarro, Antonio Sarria-Santamera, Vicent Fonollosa-Plà, Miquel Vilardell-Tarrés

Research output: Contribution to journalArticleResearchpeer-review

28 Citations (Scopus)


© 2015 Springer-Verlag Berlin Heidelberg Cardiac involvement (CI) is a known complication of SSc associated with increased mortality. Our objective was to describe a cohort of patients with SSc and CI and to assess the differences between cutaneous subsets regarding their presentation and survival. Three hundred and ninety-three Spanish patients from a single center, diagnosed with SSc, were retrospectively studied for evidence of CI using noninvasive and invasive tests from 1976 to 2011. Clinical, epidemiological, immunological and therapeutic features of patients with CI were compared to those without it and within the different cutaneous subsets of SSc. CI was present in 173 (44 %) patients. Mitral regurgitation (67 %), conduction alterations (45 %) and left ventricle diastolic dysfunction (40 %) were the most common findings. Pericardial involvement and heart failure were more frequent in diffuse SSc (dcSSc) than in limited or sine scleroderma SSc. CI accounted for 20 % of deaths, and it was an independent mortality risk factor (HR 2.1, P = 0.02), but once CI was established, classical dcSSc mortality risk factors determined mortality. Patients with dcSSc developed CI faster than limited (HR 1.9, P = 0.003) or sine SSc patients (HR 2.5, P = 0.002), specially during the first year after SSc onset. We found statistically significant differences between the 3 SSc subsets in the presentation of pericardial involvement and heart failure. CI increased the mortality and appeared at a higher rate, especially during the first year after SSc onset. Screening for heart involvement should be performed at diagnosis and during follow-up.
Original languageEnglish
JournalRheumatology International
Issue number1
Publication statusPublished - 1 Jan 2017


  • Autoimmunity
  • Cardiomyopathy
  • Fibrosis
  • Systemic sclerosis


Dive into the research topics of 'Cardiac involvement in systemic sclerosis: differences between clinical subsets and influence on survival'. Together they form a unique fingerprint.

Cite this